Similar articles

• [Dibekacin--a novel aminoglycoside antibioticl. Antimicrobial activity and parallel resistance in vitro].

  Schassan HH, Witt U. Schassan HH, et al. Arzneimittelforschung. 1979;29(2):174-8. Arzneimittelforschung. 1979. PMID: 582126 German.
• Invitro comparative evaluation of aminoglycosides at a cancer centre.

  Biswas SK, Kelkar RS. Biswas SK, et al. Indian J Cancer. 2002 Oct-Dec;39(4):135-8. Indian J Cancer. 2002. PMID: 12928571
• Resistance to gentamicin and amikacin of gram-negative organisms isolated from horses.

  Orsini JA, Benson CE, Spencer PA, Van Miller E. Orsini JA, et al. Am J Vet Res. 1989 Jun;50(6):923-5. Am J Vet Res. 1989. PMID: 2669575
• Clinical and microbiologic consequences of amikacin use during a 42-month period.

  Berk SL, Alvarez S, Ortega G, Verghese A, Holtsclaw-Berk SA. Berk SL, et al. Arch Intern Med. 1986 Mar;146(3):538-41. Arch Intern Med. 1986. PMID: 3954526
• [Amikacin: its properties and use in the clinic].

  Navashin SM, Fomina IP, Lobuseva AN, Pozdniakova VP, Samoĭlova LN. Navashin SM, et al. Antibiot Khimioter. 1988 Jul;33(7):539-45. Antibiot Khimioter. 1988. PMID: 3056304 Review. Russian. No abstract available.